Dynamics of Axon Guidance
The intricate network of the nervous system relies on the precise guidance of axons to establish functional connections between different regions of the brain and spinal cord. Axon guidance is the mechanism that ensures that neurons send axons to the correct target and plays a fundamental role in the development and function of the nervous system.
With increasing research into the molecular framework and functional significance of axonal guidance, this dynamic process lays the groundwork for multiple applications in the treatment of various neurological disorders. Creative Biolabs provides topical knowledge sharing on axon guidance, exploring its complex mechanisms, key players, recent discoveries and potential therapeutic uses.
Our Services | Descriptions |
Neurite Outgrowth/Degeneration Assay | Creative Biolabs provides validated neurite outgrowth or degeneration assays for the evaluation of potential target compounds that enhance neurite outgrowth or suppress neurite degeneration for the neurodegenerative disease therapy discovery. |
Synaptogenesis Assay | Creative Biolabs offers a range of synaptogenesis assays that allow for extensive studies of the microstructure of synaptic junctions based on immunofluorescence detection to identify mechanisms involved in synaptogenesis and neuronal plasticity as well as to drive drug screening. |
Mechanisms of Axon Guidance Axon
Axon guidance begins during embryonic development, when a neuron extends its axon to reach a specific target. This process involves a complex series of steps, including axon growth, pathfinding, and target recognition.
- Axon growth and guidance involves dynamic changes in neural cell structure. The growth cone, a dynamic structure that extends the tip of the axon, plays a key role. It senses environmental cues and guides the axon towards its target. The cytoskeleton consists of microtubules and actin filaments that undergo rearrangements to facilitate axon elongation and rotation.
Fig. 1 Growth cones change their responsiveness to the intermediate target upon arrival.1
- Axon growth and guidance involves complex molecular mechanisms. Axon guidance relies on a special set of molecules known as guidance cues. Based on their effect on axon growth, guidance cues fall into four main categories, namely, attractive cues, repulsive cues, short-range cues, and long-range cues. These cues consist of proteins or small molecules that interact with receptors on the axon growth cone to induce axon growth in the precise direction.
Fig. 2 Axon guidance within the brain.2
Key Players in Axon Guidance
Axon-directed cellular choreography is guided by molecular guidance cues present in the cellular environment. Several key receptor families are involved in axon guidance, such as the netrin receptors (DCC and UNC5), semaphorin receptors (Neuropilin and Plexin), Ephrin receptors (Eph), and Slit receptors (Robo).
For these key molecular clues, we offer high quality antibody products for your research.
Cat. No | Product Name | Clonality | Applications |
NAB-0720-Z4257 | Mouse Anti-Drosophila CNS Axon Monoclonal Antibody (CBP1118) | Monoclonal | IHC-Fr; ICC; IF; IHC-P |
NAB-0720-Z4393 | NeuroMab™ Rabbit Anti-NRP2 Monoclonal Antibody (CBP1156) | Monoclonal | WB; FC; ICC; IF; IEM |
NAB-0720-Z4906 | Rabbit Anti-ROBO4 Monoclonal Antibody (CBP1458) | Monoclonal | WB; FC |
NAB-2103-P601 | NeuroMab™ Mouse Anti-Neuropilin Monoclonal Antibody (CBP4913) | Monoclonal | WB; IP; IF; IHC-P; ELISA |
NAB-2103-P602 | NeuroMab™ Mouse Anti-Neuropilin Monoclonal Antibody (CBP4914) | Monoclonal | WB; IP; IF; IHC-P; ELISA |
NAB-2103-P857 | NeuroMab™ Mouse Anti-robo Monoclonal Antibody (CBP5068) | Monoclonal | WB; IP; IF; IHC-P; ELISA |
NAB-2103-P858 | NeuroMab™ Mouse Anti-robo Monoclonal Antibody (CBP5069) | Monoclonal | WB; IP; IF; IHC-P; ELISA |
NRP-0322-P1837 | Anti-NRP2 Monoclonal Antibody (CBP8003) | Monoclonal | WB; IHC; ICC; IP |
NRP-0322-P1841 | Anti-NRP2 Monoclonal Antibody (CBP8004) | Monoclonal | WB; IHC; ICC; IP |
We list the classification of key receptor families of axon guidance.
Receptor Families | Descriptions |
Netrin Receptors | Netrins are laminin-related proteins that can either attract or repel axons. They work through three types of receptors: Deleted in Colorectal Cancer (DCC), Neogenin, and various UNC5 isoforms. DCC and Neogenin mediate attraction, while UNC5 mediates repulsion. |
Slit and Robo Receptors | Slits are a family of secreted proteins recognized by Roundabout (Robo) receptors. Slit-Robo interactions are crucial for the proper formation of the nervous system by repelling axons away from certain areas. |
Ephrin and Eph Receptors | Ephrins and Eph receptors constitute the largest family of guidance cues. Ephrins are membrane-bound ligands that bind to Eph receptors, which can induce bidirectional signaling. This family is known for their role in establishing topographic maps and repulsive guidance. |
Semaphorin and Plexin/Neuropilin Receptors | Semaphorins are a large family of secreted and membrane-bound proteins. They interact with Plexin and Neuropilin receptors to repel axons away from inappropriate areas. |
Neuropilin and VEGF Receptors | Apart from Plexins, Neuropilins can also act as receptors for VEGF (Vascular Endothelial Growth Factor), playing crucial roles in axon guidance, especially in the development of the vasculature. |
L1CAM and NCAM Receptors | The cell adhesion molecules (CAMs), including L1CAM and NCAM, are also implicated in axon guidance. They facilitate axon extension by promoting adhesion between the growth cone and the extracellular environment. |
Integrin Receptors | Integrins are transmembrane receptors that facilitate cell-extracellular matrix (ECM) adhesion. They can also mediate bidirectional signaling and influence cell migration, including that of the axonal growth cone. |
These receptors usually don't function in isolation but often act in concert, integrating signals from multiple guidance cues to navigate the complex environment. The misregulation of these pathways can lead to neurodevelopmental disorders and neurological diseases.
Applications in Neuroscience and Medicine
By controlling the growth path of axons, researchers can create customized neural networks in vitro for disease modeling, drug discovery, or regenerative medicine.
- Disruption of axonal guidance may have profound effects on neurological health. Spinal cord injuries, traumatic brain injuries, or neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease are typically characterized by loss or impairment of axonal projections to the site of injury.
- Understanding the molecular mechanisms of axon pathfinding is likewise crucial for managing brain tumors. Gliomas, a type of brain cancer, hijack the existing axon guidance system and thus spread throughout the brain. By understanding this mechanism, we can develop strategies to prevent tumor invasion.
- Axonal guidance is not limited to embryonic development; it also plays a role in neural regeneration and repair. Utilizing the principles of axon guidance is essential to facilitate proper regeneration and restore functional neural connectivity. Researchers are exploring strategies to enhance axon guidance in the context of nerve repair, with the promise of treating traumatic injuries and neurodegenerative diseases.
As the technology has evolved, so has the research on axon guidance. For example, optogenetic tools enable precise control of neuronal activity, allowing researchers to manipulate and study axon growth in real time. gene manipulation techniques such as CRISPR-Cas9 provide unprecedented opportunities to modify genes involved in axon guidance, allowing for a deeper understanding of the molecular players in this complex process.
Our growing understanding of axonal guidance offers great potential for treating a wide range of neurological disorders. As technology advances and our knowledge deepens, Creative Biolabs would like to serve as your partner in advancing the emergence of new discoveries and transformative applications in neuroscience.
References
- Stoeckli, Esther. "Where does axon guidance lead us?." F1000Research 6 (2017).
- Stoeckli, Esther. "Understanding axon guidance: are we nearly there yet?." Development 145.10 (2018): dev151415.
Related Scientific Resources
- NeuroMab™ Anti-TREM2 BBB Shuttle Antibody(NRZP-1022-ZP4114) (Cat#: NRZP-1022-ZP4114)
- NeuroMab™ Anti-Tau Antibody(NRP-0422-P1684) (Cat#: NRP-0422-P1684)
- NeuroMab™ Anti-Tau Antibody(NRP-0422-P2293) (Cat#: NRP-0422-P2293)
- NeuroMab™ Anti-Tau Antibody(NRP-0422-P2275) (Cat#: NRP-0422-P2275)
- NeuroMab™ Anti-Integrin αvβ8 BBB Shuttle Antibody(NRZP-1222-ZP1218) (Cat#: NRZP-1222-ZP1218)
- NeuroMab™ Anti-Tau Antibody(NRP-0422-P1760) (Cat#: NRP-0422-P1760)
- NeuroMab™ Mouse Anti-SHANK3 Monoclonal Antibody (CBP929) (Cat#: NAB-0720-Z3477)
- NeuroMab™ Anti-CD20 Antibody(NRP-0422-P1230) (Cat#: NRP-0422-P1230)
- NeuroMab™ Anti-GD2 Antibody(NRZP-1222-ZP767) (Cat#: NRZP-1222-ZP767)
- NeuroMab™ Anti-SEZ6 Antibody(NRP-0422-P515) (Cat#: NRP-0422-P515)
- Rat Muller Cell (Cat#: NCL2110P040)
- C57 Brain Cortex Neurons [Mouse] (Cat#: NCC20-9PZ48)
- Immortalized Human Cerebral Microvascular Endothelial Cells (Cat#: NCL-2108-P020)
- Rat Immortalized Retinal Muller Cell Line rMC-1 (Cat#: NCL-2106-S93)
- Human Brain Vascular Pericytes (Cat#: NCL-21P6-015)
- Human Brain Vascular Adventitial Fibroblasts (Cat#: NCL-21P6-014)
- iNeu™ Human Oligodendrocyte Progenitor Cells (OPCs) (Cat#: NCL-2103-P49)
- Mouse Microglia from C57BL/6 (Cat#: NCL-21P6-082)
- Mouse Glioma Cell Line GL-261-Luc (Cat#: NCL-2108P06)
- iNeu™ Human Midbrain Dopaminergic Neurons (Cat#: NCL-21P6-003)
- Human Poly ADP ribose polymerase,PARP Assay Kit (Cat#: NRZP-1122-ZP62)
- Alpha Synuclein Aggregation Kit (Cat#: NRZP-1122-ZP15)
- Human Tau Aggregation Kit (Cat#: NRP-0322-P2173)
- Beta Amyloid (1-42), Aggregation Kit (Cat#: NRZP-0323-ZP200)
- Alpha-Synuclein Aggregation Assay Kit (Cat#: NRZP-1122-ZP37)
- Human GFAP ELISA Kit [Colorimetric] (Cat#: NPP2011ZP383)
- Amyloid beta 1-42 Kit (Cat#: NRP-0322-P2170)
- Beta Amyloid (1-40), Aggregation Kit (Cat#: NRZP-0323-ZP199)
- Dextran, Cy5 Labeled, 2000 kDa (Cat#: NRZP-0722-ZP22)
- AAV-mDLX-CRE-tdTomato (Cat#: NRZP-0622-ZP721)
- PRV-CAG-EGFP (Cat#: NTA-2011-ZP14)
- VSV-eGFP (Cat#: NTA-2011-ZP20)
- pAAV-syn-FLEX-jGCaMP8f-WPRE (Cat#: NTA-2106-P064)
- AAV2 Full Capsids, Reference Standards (Cat#: NTC2101070CR)
- Dextran, NHS Activated, 40 kDa (Cat#: NRZP-0722-ZP124)
- AAV2/9-hEF1a-DIO-mCherry-P2A-TetTox-WPRE-pA (Cat#: NTA-2012-ZP268)
- pAAV-syn-jGCaMP8m-WPRE (Cat#: NTA-2106-P062)
- AAV2/9-hSyn-Flpo-EGFP-WPRE-pA (Cat#: NTA-2012-ZP149)
- App Rat amyloid beta (A4) precursor protein (App)(NM_019288) ORF clone, Untagged (Cat#: NEP-0421-R0053)
- Lenti of Human TAR DNA binding protein (TARDBP) (NM_007375) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0832)
- Human superoxide dismutase 3, extracellular (SOD3) (NM_003102) ORF clone, Untagged (Cat#: NEP-0521-R0808)
- Tau Antisense Oligonucleotide (IONIS-MAPTRx) (Cat#: NV-2106-P29)
- Human presenilin 1 (PSEN1), transcript variant 2 (NM_007318) ORF clone, TurboGFP Tagged (Cat#: NEP-0421-R0140)
- Human huntingtin (HTT) (NM_002111) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0497)
- Rat Parkinson disease (autosomal recessive, juvenile) 2, parkin (Park2) (NM_020093) ORF clone/lentiviral particle, Myc-DDK Tagged (Cat#: NEP-0621-R0041)
- Mouse Parkinson disease (autosomal recessive, early onset) 7 (Park7) (NM_020569) clone, Untagged (Cat#: NEP-0621-R0133)
- Human superoxide dismutase 1, soluble (SOD1) (NM_000454) ORF clone, TurboGFP Tagged (Cat#: NEP-0521-R0748)
- Human huntingtin-associated protein 1 (HAP1) transcript variant 2 (NM_177977) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0676)
- NeuroBiologics™ Pig Cerebrospinal Fluid (Cat#: NRZP-0822-ZP498)
- NeuroBiologics™ Rat Cerebrospinal Fluid (Cat#: NRZP-0822-ZP496)
- NeuroBiologics™ Monkey Cerebrospinal Fluid (Cat#: NRZP-0822-ZP495)
- NeuroBiologics™ Human Cerebrospinal Fluid (Cat#: NRZP-0822-ZP491)
- NeuroBiologics™ Mouse Cerebrospinal Fluid (Cat#: NRZP-0822-ZP497)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP509)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP510)
- NeuroPro™ Anti-SGSH BBB Shuttle Protein (Cat#: NRZP-0423-ZP505)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP498)
- NeuroPro™ Anti-IDS BBB Shuttle Protein (Cat#: NRZP-0423-ZP503)
- NeuroPro™ Anti-ASA BBB Shuttle Protein (Cat#: NRZP-0423-ZP504)
- NeuroPro™ Anti-Erythropoietin BBB Shuttle Protein (Cat#: NRZP-0423-ZP499)
- NeuroPro™ Anti-EPO BBB Shuttle Protein (Cat#: NRZP-0423-ZP508)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP501)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP500)